Laman UtamaSLNCF • OTCMKTS
add
Silence Therapeutics plc
Tutup sebelumnya
$0.95
Julat tahun
$0.50 - $14.75
Permodalan pasaran
158.67J USD
Bilangan Purata
9.53K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
OTCMKTS
Berita pasaran
Invezz
1 hari lalu
Amaran risiko: ‘kemelesetan sederhana’ boleh menjejaskan tahap S&P 500 kepada 3,700
0.74%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 25.55J | 1,180.58% |
Perbelanjaan pengendalian | 16.51J | 144.71% |
Pendapatan bersih | 10.34J | 159.17% |
Margin untung bersih | 40.47 | 104.62% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 6.92J | 214.46% |
Kadar cukai berkesan | 46.54% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 147.33J | 114.18% |
Jumlah aset | 202.64J | 69.64% |
Jumlah liabiliti | 68.61J | -29.60% |
Jumlah ekuiti | 134.02J | — |
Syer tertunggak | 47.22J | — |
Harga kepada buku | 0.33 | — |
Pulangan pada aset | 8.17% | — |
Pulangan pada modal | 13.41% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 10.34J | 159.17% |
Tunai daripada operasi | -27.62J | -91.10% |
Tunai daripada pelaburan | 62.32J | 5,532.17% |
Tunai daripada pembiayaan | 1.40J | -88.85% |
Perubahan bersih dalam tunai | 42.62J | 1,757.25% |
Aliran tunai bebas | -2.14J | -67.96% |
Perihal
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
Diasaskan
1994
Tapak web
Pekerja
116
